orforglipron · GLP-1 receptor agonist

Foundayo

Approved April 1, 2026; Lilly sources remain manual-verified while backend access is blocked.

Manual verified

Basis split

Why are there two numbers?

Foundayo exposes a treatment-regimen number that is the safer clinical comparison anchor, a more favorable efficacy-estimand headline, and a separate regardless-of-completion public framing. Keep the treatment-regimen anchor primary.

Efficacy anchors

3 anchors

  • Label-safe anchor

    TR Est.Week 72

    Trial: ATTAIN-1

    Adults with obesity or overweight without diabetes

    11.2%

    Foundayo Lilly Medical body weight page

    Apr 13, 2026 2:20 PM

    Why this number?

    Treatment-regimen estimand regardless of treatment discontinuation.

    Dose context: 17.2 mg

  • Conservative public anchor

    ROCWeek 72

    Trial: ATTAIN-1

    Adults with obesity or overweight without diabetes

    11.1%

    FDA approves Lilly's Foundayo

    Apr 1, 2026

    Why this number?

    Investor release headline for participants regardless of trial completion.

    Dose context: 17.2 mg

  • Headline high-dose anchor

    Eff. Est.Week 72

    Trial: ATTAIN-1

    Adults with obesity or overweight without diabetes

    12.4%

    Foundayo Lilly Medical body weight page

    Apr 13, 2026 2:20 PM

    Why this number?

    Efficacy estimand at the highest approved dose if participants stayed on treatment.

    Dose context: 17.2 mg

Price anchors

4 anchors

  • Starting self-pay

    Starting

    Dose context: 0.8 mg

    Program: LillyDirect self-pay

    $149/mo

    LillyDirect Foundayo

    Apr 13, 2026 2:25 PM

    Why this number?

    Lowest-dose self-pay path.

    Current starting self-pay price on LillyDirect.

    Patient segment: cash_pay

    Manual-verified because plain server-side requests currently hit a Cloudflare challenge.

  • Step-up self-pay

    Step-Up

    Dose context: 2.5 mg

    Program: LillyDirect self-pay

    $199/mo

    LillyDirect Foundayo

    Apr 13, 2026 2:25 PM

    Why this number?

    Second titration step.

    Current step-up self-pay price on LillyDirect.

    Patient segment: cash_pay

    Manual-verified because plain server-side requests currently hit a Cloudflare challenge.

  • High-dose journey self-pay

    Journey

    Dose context: 14.5 mg

    Program: Foundayo purchase offer

    $299/mo

    Foundayo full terms and conditions

    Apr 13, 2026 2:30 PM

    Why this number?

    Purchase offer price applies with refill within 45 days.

    Current high-dose purchase offer with refill within 45 days.

    Patient segment: cash_pay

    High-dose purchase offer requires refill within 45 days of the previous fill.

  • High-dose regular self-pay

    Regular

    Dose context: 14.5 mg

    Program: Foundayo purchase offer

    $349/mo

    Foundayo full terms and conditions

    Apr 13, 2026 2:30 PM

    Why this number?

    Regular high-dose self-pay path without the 45-day refill window.

    Current regular high-dose price without a qualifying refill.

    Patient segment: cash_pay

    Regular high-dose price applies without a refill within 45 days.

Source ledger

4 linked

Timeline

Change history

View all changes →
low severity

Observed Foundayo price anchor high dose regular self pay

Observed Foundayo high dose regular self pay at $349/month from Foundayo full terms and conditions.

View source
low severity

Observed Foundayo price anchor high dose regular self pay

Observed Foundayo high dose regular self pay at $349/month from Foundayo full terms and conditions.

View source
low severity

Observed Foundayo price anchor high dose journey self pay

Observed Foundayo high dose journey self pay at $299/month from Foundayo full terms and conditions.

View source
low severity

Observed Foundayo price anchor high dose journey self pay

Observed Foundayo high dose journey self pay at $299/month from Foundayo full terms and conditions.

View source
low severity

Observed Foundayo price anchor maintenance self pay

Observed Foundayo maintenance self pay at $299/month from LillyDirect Foundayo.

View source
low severity

Observed Foundayo price anchor maintenance self pay

Observed Foundayo maintenance self pay at $299/month from LillyDirect Foundayo.

View source
low severity

Observed Foundayo price anchor step up self pay

Observed Foundayo step up self pay at $199/month from LillyDirect Foundayo.

View source
low severity

Observed Foundayo price anchor starting self pay

Observed Foundayo starting self pay at $149/month from LillyDirect Foundayo.

View source
low severity

Observed Foundayo efficacy anchor efficacy estimand

Observed Foundayo efficacy estimand efficacy anchor at 12.4% from Foundayo Lilly Medical body weight page.

View source
low severity

Observed Foundayo efficacy anchor treatment regimen estimand

Observed Foundayo treatment regimen estimand efficacy anchor at 11.2% from Foundayo Lilly Medical body weight page.

View source
low severity

Observed Foundayo efficacy anchor regardless of completion

Observed Foundayo regardless of completion efficacy anchor at 11.1% from FDA approves Lilly's Foundayo.

View source